Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2071-2019Class I

ELLIPSE VR, REF: CD1377-36QC Implantable cardioverter defibrillators (ICDs)

Abbott Medical / initiated 2019-06-20 / Terminated / root cause: manufacturing process

St Jude Medical Inc. began a recall of ELLIPSE VR, REF: CD1377-36QC Implantable cardioverter defibrillators (ICDs) on . FDA classified it as Class I and gives the reason as "Electrical failures were identified in cardioverter defibrillators (ICDs) due to damaged aluminum wires. ICDs may contain electrical wire connections which may not be completely insulated. The potential patient impact...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2071-2019
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Abbott Medical
Product
ELLIPSE VR, REF: CD1377-36QC Implantable cardioverter defibrillators (ICDs)
Product code
LWS Implantable Cardioverter Defibrillator (Non-Crt)
Reason for recall
Electrical failures were identified in cardioverter defibrillators (ICDs) due to damaged aluminum wires. ICDs may contain electrical wire connections which may not be completely insulated. The potential patient impact could be the inability to deliver high voltage therapy. There is no available option to verify the vulnerability status for implanted devices.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On 06/20/19, Sales Representatives visited impacted customer accounts to provide talking points that included the reason for recall and to retrieve affected devices. On 06/21/19, hand-delivery of Urgent Medical Device Recall Notices, to physicians supporting implanted patients, commenced. Customers were informed that there is no available option to verify the vulnerability status for implanted devices. Device explant and replacement are recommended. Customers were advised to: 1) Review the device model and serial numbers in the appendix of this letter to identify the impacted patients and return the acknowledgement form to your sales representative; and 2) Device explant and replacement are recommended. The recalling firm will work with customers to provide a replacement device. A copy of this letter is available on https://www.cardiovascular.abbott/us/en/hcp/resources/product/advisories.html. Customers with additional questions were encouraged to call 1-800-727-7846 (Opt3), 8:30am - 5:30pm Central Time, Monday thru Friday.
Quantity in commerce
47
Distribution
Worldwide distribution. US nationwide, and countries: DE, FR, IT, ES, NL, PT, SE, HU, DK, PL, IL, GP, DZ, CH, SA, SK, LU, NZ, VN, and NO
Product codes and lots
Serial Number: 1281828, 1281840, 1282688, 1282724, 1282734, 1283113, 1283627, 1283633, 1283634, 1283639, 1283641, 1283643, 1283646, 1283648, 1283656, 1283657, 1283659, 1283660, 1283672, 1283680, 1283681, 1283683, 1283689, 1283690, 1283692, 1283695, 1283697, 1283703, 1283704, 1283708, 1283742, 1283747, 1283749, 1283766, 1283772, 1283780, 1283783, 1283784, 1283788, 1283832, 1283838, 1283845, 1283868, 1283884, 9831441, 9831445, 9831759

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2071-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2070-2019Class ITerminatedVoluntary: Firm initiated
Z-2071-2019Class ITerminatedVoluntary: Firm initiated
Z-2072-2019Class ITerminatedVoluntary: Firm initiated
Z-2073-2019Class ITerminatedVoluntary: Firm initiated
Z-2074-2019Class ITerminatedVoluntary: Firm initiated
Z-2075-2019Class ITerminatedVoluntary: Firm initiated